Beneficial effect of statins in multiple sclerosis: is it dose-dependent?
Sena
Armando
A
Pedrosa
Rui
R
Morais
M Graça
MG
D000069059:Atorvastatin; D004305:Dose-Response Relationship, Drug; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage*; D008148:Lovastatin / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage; D019821:Simvastatin / Q000008:administration & dosage; D016896:Treatment Outcome
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007155:Immunologic Factors; D011758:Pyrroles; D008148:Lovastatin; D000069059:Atorvastatin; D019821:Simvastatin